newsdeck
← Back to homepage

AstraZeneca ditches lung cancer treatment trial

Sources
2
Coverage
Limited spectrum
Sentiment
+0.20
◀ Left 100%Centre 0%Right 0% ▶
How we rate bias →
This story is currently only covered by 2 sources from a limited part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(2)
Independent Business
AstraZeneca ditches lung cancer treatment trial
The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.
17 Aug, 07:22
Evening Standard
Neutral
AstraZeneca ditches lung cancer treatment trial
The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.
17 Aug, 07:22
Centre
(0)
No coverage from this perspective yet
Right
(0)
No coverage from this perspective yet